LAUREL, MD -- (MARKET WIRE) -- December 11, 2006 -- BioServe Biotechnologies, a leader for fast, economical processing and analyses of genomic content from biological samples, today introduced its new DNA Methylation Analysis Service using Sequenom, Inc.'s (NASDAQ: SQNM) MassARRAY® System and EpiTYPER™ methodology. DNA methylation markers are a new and important class of biomarkers that are significant because of their correlation to gene activity. High levels of cytosine methylation in genomic regions (CpG islands) are often associated with decreased or completely inhibited gene expression. Researchers now believe that DNA methylation patterns play an important role in early cancer detection and prognosis. BioServe's Methylation Analysis Service will aid researchers' understanding of methylation patterns with quantitative results in the form of methylation ratios in targeted genomic regions.
